- Home
- IMNN vs OMH Comparison
IMNN vs OMH Comparison
Compare IMNN & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- OMH
- Stock Information
- Founded
- IMNN 1982
- OMH 2015
- Country
- IMNN United States
- OMH Singapore
- Employees
- IMNN N/A
- OMH N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- OMH Real Estate
- Sector
- IMNN Health Care
- OMH Finance
- Exchange
- IMNN Nasdaq
- OMH Nasdaq
- Market Cap
- IMNN 12.1M
- OMH 13.6M
- IPO Year
- IMNN 1985
- OMH 2023
- Fundamental
- Price
- IMNN $0.77
- OMH $1.48
- Analyst Decision
- IMNN Buy
- OMH Hold
- Analyst Count
- IMNN 2
- OMH 1
- Target Price
- IMNN $14.00
- OMH N/A
- AVG Volume (30 Days)
- IMNN 2.3M
- OMH 5.5M
- Earning Date
- IMNN 08-13-2025
- OMH 07-11-2025
- Dividend Yield
- IMNN N/A
- OMH N/A
- EPS Growth
- IMNN N/A
- OMH N/A
- EPS
- IMNN N/A
- OMH N/A
- Revenue
- IMNN N/A
- OMH $7,976,578.00
- Revenue This Year
- IMNN N/A
- OMH $28.40
- Revenue Next Year
- IMNN N/A
- OMH $23.07
- P/E Ratio
- IMNN N/A
- OMH N/A
- Revenue Growth
- IMNN N/A
- OMH 117.53
- 52 Week Low
- IMNN $0.37
- OMH $0.59
- 52 Week High
- IMNN $3.65
- OMH $6.20
- Technical
- Relative Strength Index (RSI)
- IMNN 40.86
- OMH 46.07
- Support Level
- IMNN $0.70
- OMH $1.32
- Resistance Level
- IMNN $0.86
- OMH $1.58
- Average True Range (ATR)
- IMNN 0.10
- OMH 0.12
- MACD
- IMNN -0.05
- OMH 0.02
- Stochastic Oscillator
- IMNN 10.34
- OMH 43.98
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.